Prot #U31402-A-J101: Phase 1/2, Multicenter, Open-label, Multiple Dose First-In-Human Study of U3-1402, in Subjects with HER3 Positive Metastatic Breast Cancer

Project: Research project

Project Details

StatusActive
Effective start/end date3/13/193/13/22

Funding

  • Quintiles, Inc. (Prot #U31402-A-J101)
  • Daiichi Sankyo, Inc. (Prot #U31402-A-J101)